Lenalidomide in Combination With Microtransplantation as Post-remission Therapy in AML
Stopped Slow Accrual
Conditions
- Acute Myeloid Leukemia (AML)
- Acute Myelocytic Leukemia
- Acute Myelogenous Leukemia
- Acute Granulocytic Leukemia
- Acute Non-Lymphocytic Leukemia
Interventions
- DRUG: Lenalidomide
- GENETIC: HLA-mismatched stem-cell Microtransplantation
- DRUG: Cytarabine
Sponsor
Massachusetts General Hospital
Collaborators